These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15902343)

  • 1. Treatment of benign giant cell tumours of bone in Singapore.
    Lim YW; Tan MH
    Ann Acad Med Singap; 2005 Apr; 34(3):235-7. PubMed ID: 15902343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant cell tumour of bone in the appendicular skeleton: an analysis of 276 cases.
    Xing R; Yang J; Kong Q; Tu C; Zhou Y; Duan H
    Acta Orthop Belg; 2013 Dec; 79(6):731-7. PubMed ID: 24563982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended intralesional curettage preferred over resection-arthrodesis for giant cell tumour of the distal radius.
    Abuhejleh H; Wunder JS; Ferguson PC; Isler MH; Mottard S; Werier JA; Griffin AM; Turcotte RE
    Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):11-17. PubMed ID: 31297594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating giant cell tumours with curettage, electrocautery, burring, phenol irrigation, and cementation.
    Moon MS; Kim SS; Moon JL; Kim SS; Moon H
    J Orthop Surg (Hong Kong); 2013 Aug; 21(2):209-12. PubMed ID: 24014786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy.
    Trieb K; Bitzan P; Lang S; Dominkus M; Kotz R
    Eur J Surg Oncol; 2001 Mar; 27(2):200-2. PubMed ID: 11289759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar local control between phenol- and ethanol-treated giant cell tumors of bone.
    Lin WH; Lan TY; Chen CY; Wu K; Yang RS
    Clin Orthop Relat Res; 2011 Nov; 469(11):3200-8. PubMed ID: 21732023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for recurrence of giant cell tumours of bone.
    Siddiqui MA; Seng C; Tan MH
    J Orthop Surg (Hong Kong); 2014 Apr; 22(1):108-10. PubMed ID: 24781627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of 51 intralesionally treated cases with progressed giant cell tumor of the bone: local adjuvant use of hydrogen peroxide reduces the risk for tumor recurrence.
    Omlor GW; Lange J; Streit M; Gantz S; Merle C; Germann T; Mechtersheimer G; Fellenberg J; Lehner B
    World J Surg Oncol; 2019 Apr; 17(1):73. PubMed ID: 31014317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenol as an adjuvant for local control in the treatment of giant cell tumour of the bone.
    Dürr HR; Maier M; Jansson V; Baur A; Refior HJ
    Eur J Surg Oncol; 1999 Dec; 25(6):610-8. PubMed ID: 10556009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.
    Agarwal MG; Gundavda MK; Gupta R; Reddy R
    Clin Orthop Relat Res; 2018 Sep; 476(9):1773-1782. PubMed ID: 30794215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanol as a local adjuvant for giant cell tumor of bone.
    Jones KB; DeYoung BR; Morcuende JA; Buckwalter JA
    Iowa Orthop J; 2006; 26():69-76. PubMed ID: 16789453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones.
    van der Heijden L; van de Sande MA; Dijkstra PD
    Acta Orthop; 2012 Aug; 83(4):401-5. PubMed ID: 22880716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
    Gouin F; Dumaine V;
    Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
    Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case analysis on treatment and recurrence of giant cell tumor of bone].
    Zhang Z; Zhu B; Sun T
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1007-10. PubMed ID: 17140075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
    Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
    World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Freezing Nitrogen Ethanol Composite May be a Viable Approach for Cryotherapy of Human Giant Cell Tumor of Bone.
    Wu PK; Chen CF; Wang JY; Chen PC; Chang MC; Hung SC; Chen WM
    Clin Orthop Relat Res; 2017 Jun; 475(6):1650-1663. PubMed ID: 28197783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long bones giant cells tumors: treatment by curretage and cavity filling cementation.
    Fraquet N; Faizon G; Rosset P; Phillipeau J-; Waast D; Gouin F
    Orthop Traumatol Surg Res; 2009 Oct; 95(6):402-6. PubMed ID: 19767256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of giant-cell tumors of long bones with curettage and bone-grafting.
    Blackley HR; Wunder JS; Davis AM; White LM; Kandel R; Bell RS
    J Bone Joint Surg Am; 1999 Jun; 81(6):811-20. PubMed ID: 10391546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for local recurrence in extremity-located giant cell tumours of bone with pathological fracture.
    Medellin MR; Fujiwara T; Tillman RM; Jeys LM; Gregory J; Stevenson JD; Parry M; Abudu A
    Bone Joint J; 2018 Dec; 100-B(12):1626-1632. PubMed ID: 30499317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.